Production Planning for Pharmaceutical Companies Under Non-Compliance Risk

Operations Research Proceedings, pp. 545.0-550, 2011.

Cited by: 4|Views1
EI

Abstract:

This paper addresses a production planning setting for pharmaceutical companies under the risk of failing quality inspections that are undertaken by the regulatory authorities to ensure good manufacturing practices. A staged decision model is proposed where the regulatory authority is considered an adversary with limited inspection budget...More

Code:

Data:

Get fulltext within 24h
Bibtex
Your rating :
0

 

Tags
Comments